Bioactive Bone Substitutes Plc (BBS) is a Finnish health technology company, which develops, designs and manufactures innovative bioactive bone-graft substitute implants. Our unique bioactive implants provide clinical and financial benefits for treatment of patients with bone defects and healing problems.
Academic and clinical tests have demonstrated that ARTEBONE® has a superior capability in stimulating bone healing. All the steps required for the CE certification application have been completed. ARTEBONE® is an injectable paste in a ready-to-use syringe including a natural spectrum of bone growth factors.
Technology used in ARTEBONE® has required over 20 years of extensive research and development work and is protected by 5 global patent families.
BBS was established in 2003 and it is located in Oulu, Finland, with a fully-owned EU-certified production facility in Reisjärvi.
Our mission is to secure bone healing and to improve the surgical outcomes of bone substitutes for the benefit of both the patient and surgeon. We aim to be one of the leading players in the field of bioactive implants.
ARTEBONE® is backed by more than 20 years of scientific research.